Sign in
Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID
Rishi P. Singh, MD
Annual Meeting Talks
2019
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022
Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy
Andrew N. Antoszyk, MD FASRS
2016
Category: Retinal Detachment